Concepedia

Ting Yu

TY

Statistics

Publications

8

Citations

407

H-Index

8

Active since

2007

Affiliations

AstraZeneca (United States)(Current)

The Maria Sklodowska-Curie National Research Institute of Oncology

Vita-Salute San Raffaele University

IRCCS Ospedale San Raffaele

University Hospital Plzen

Ting Yu is an author at AstraZeneca (United States) specializing in hematology, health sciences, and immunology.

Top concepts

Publications per year

2007–2025

8

Publications

8

Adipocytokines and breast cancer risk

Weikai Hou, Yuxin Xu, Ting Yu et al. · Chinese Medical Journal · 2007 · 143 citations · Full text

Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results

Paolo Ghia, Andrzej Pluta, Małgorzata Wach et al. · HemaSphere · 2022 · 95 citations · Full text

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia

Jennifer R. Brown, John F. Seymour, Wojciech Jurczak et al. · New England Journal of Medicine · 2025 · 65 citations

Acalabrutinib ± obinutuzumab versus obinutuzumab + chlorambucil in treatment-naïve chronic lymphocytic leukemia: Five-year follow-up of ELEVATE-TN.

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · Journal of Clinical Oncology · 2022 · 26 citations

, , +17

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors

Shringi Sharma, Xavier Pépin, Lianqing Zheng et al. · Clinical Pharmacology in Drug Development · 2022 · 25 citations · Full text

1–5 of 8